GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunmax Biotechnology Co Ltd (ROCO:4728) » Definitions » Scaled Net Operating Assets

Sunmax Biotechnology Co (ROCO:4728) Scaled Net Operating Assets : 0.66 (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Sunmax Biotechnology Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sunmax Biotechnology Co's operating assets for the quarter that ended in Dec. 2024 was NT$1,517.4 Mil. Sunmax Biotechnology Co's operating liabilities for the quarter that ended in Dec. 2024 was NT$277.5 Mil. Sunmax Biotechnology Co's Total Assets for the quarter that ended in Sep. 2024 was NT$1,867.7 Mil. Therefore, Sunmax Biotechnology Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.66.


Sunmax Biotechnology Co Scaled Net Operating Assets Historical Data

The historical data trend for Sunmax Biotechnology Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunmax Biotechnology Co Scaled Net Operating Assets Chart

Sunmax Biotechnology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.33 0.39 0.69 0.71

Sunmax Biotechnology Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.38 0.08 0.38 0.66

Competitive Comparison of Sunmax Biotechnology Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Sunmax Biotechnology Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunmax Biotechnology Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunmax Biotechnology Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Sunmax Biotechnology Co's Scaled Net Operating Assets falls into.


;
;

Sunmax Biotechnology Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sunmax Biotechnology Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(1517.431-277.481)/1746.342
=0.71

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1850.654 - 333.223
=1517.431

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=337.816 - 54.344 - 5.991
=277.481

Sunmax Biotechnology Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(1517.431-277.481)/1867.661
=0.66

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1850.654 - 333.223
=1517.431

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=337.816 - 54.344 - 5.991
=277.481

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunmax Biotechnology Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Sunmax Biotechnology Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunmax Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
Huandong Road, New Urban District, 1st Floor, No. 10, Lane 31, Section 1, Tainan Science Industrial Park, Tainan, TWN
Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.

Sunmax Biotechnology Co Headlines

No Headlines